Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Future Value of TLT.v

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Feb 06, 2024 6:12pm

410 Views

Post# 35866407

RE:RE:The Future Value of TLT.v

Here are Dr Mandels own words as per the Globe and Mail article..

...the benefits of Rutherrin as an intravenous administered drug in combination with radiotherapy, in our preclinical research it strongley supports achieving even higher tumour destruction and a complete response in patients by combining Theralases PDC with immunotherapy for various cancers.

Notice he says..in patients...meaning humans.

So there is still a bit of mystery...thats why the stock price is still low. Once proven its $10++
Remember the old saying...buy on mystery...sell on history.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?